Lymphoma Clinical Trials

Active, Not Recruiting

Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome

NCT04652960

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

UCHealth University of Colorado Hospital Aurora, Colorado, United States

UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States

UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States

View all 17 locations

View Trial Details

Active, Not Recruiting

Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma

NCT04458922

Conditions: Central Chondrosarcoma, Grade 2, Central Chondrosarcoma, Grade 3, Dedifferentiated Chondrosarcoma, +17 more
Locations: USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

UF Health Cancer Institute - Gainesville Gainesville, Florida, United States

Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View all 15 locations

View Trial Details

Active, Not Recruiting

A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) Cancer

NCT06139406

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Austin Hospital Heidelberg, Australia

The Alfred Hospital Melbourne, Australia

Linear Clinical Research Ltd Nedlands, Australia

Scientia Clinical Research Randwick, Australia

View Trial Details

Active, Not Recruiting

Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas

NCT03984448

Conditions: Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Diffuse Large B-cell Lymphoma, Double-Expressor Lymphoma, +16 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

View all 635 locations

View Trial Details

Active, Not Recruiting

Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia

NCT02003222

Conditions: Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt Lymphoma, +20 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

View all 545 locations

View Trial Details

Active, Not Recruiting

A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

NCT05421663

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: City of Hope Duarte, California, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

University of Iowa Hospital and Clinics Iowa City, Iowa, United States

University of Kentucky Medical Center Lexington, Kentucky, United States

View all 32 locations

View Trial Details

Active, Not Recruiting

A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)

NCT06660563

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Concord Hospital Concord, Australia

St Vincents Hospital Melbourne Fitzroy, Australia

Macquarie University Hospital North Ryde, Australia

Hosp Univ Vall D Hebron Barcelona, Spain

View Trial Details

Active, Not Recruiting

Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

NCT07387471

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 279178 Nagoya, Aichi-ken, Japan

Nagoya City University Hospital /ID# 277580 Nagoya, Aichi-ken, Japan

University of Fukui Hospital /ID# 279173 Yoshida-gun, Fukui, Japan

Kyushu University Hospital /ID# 277582 Fukuoka, Japan

View all 17 locations

View Trial Details

Active, Not Recruiting

A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

NCT03888105

Conditions: B-cell Non-Hodgkin Lymphoma (B-NHL), Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Rush University Medical Center Chicago, Illinois, United States

University of Iowa Iowa City, Iowa, United States

Norton Cancer Institute Louisville, Kentucky, United States

Tufts Medical Center Boston, Massachusetts, United States

View all 119 locations

View Trial Details

Active, Not Recruiting

Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia

NCT06323447

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Diffuse Large B Cell Lymphoma, +18 more
Locations: University of Hawaii Cancer Center Honolulu, Hawaii, United States

Norton Healthcare Cancer Center Louisville, Kentucky, United States

Massachussetts General Hospital Boston, Massachusetts, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions